Literature DB >> 12391264

The mutant androgen receptor T877A mediates the proliferative but not the cytotoxic dose-dependent effects of genistein and quercetin on human LNCaP prostate cancer cells.

Marcello Maggiolini1, Adele Vivacqua, Amalia Carpino, Daniela Bonofiglio, Giovanna Fasanella, Michele Salerno, Didier Picard, Sebastiano Andó.   

Abstract

High consumption of soybean products, such as phytoestrogens, has been hypothesized to contribute to a reduced incidence of prostate cancer in Southeast Asian people, although there have been inconsistent results among studies. Human LNCaP cells, extensively used as a model for androgen-dependent prostate tumor, express the androgen receptor (AR) mutant T877A promiscuously transactivated by estrogens and other ligands, which may further facilitate cancer progression. Here, for the first time to our knowledge, we demonstrate that genistein and quercetin, two phytoestrogens abundantly present in soybeans, activate either the AR mutant T877A in LNCaP or in transfected Chinese hamster ovary cells. This observation is supported by their capability to induce AR accumulation in the nuclear compartment of LNCaP together with mRNA down-regulation of the androgen target genes AR and PAP, and PSA up-regulation. Of interest, at concentrations eliciting transcriptional activity, both genistein and quercetin stimulate LNCaP cell growth, whereas at high levels, they become cytotoxic independently of AR expression, as ascertained in steroid receptor-negative Hela cells. The results of our study provide evidence that phytoestrogens may regulate several signaling processes in LNCaP cells; however, further studies are needed to assess their potential capability to restrain prostate tumor progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391264     DOI: 10.1124/mol.62.5.1027

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

1.  Regulation of the neuroendocrine axis in male rats by soy-based diets is independent of age and due specifically to isoflavone action†.

Authors:  Bamidele O Jeminiwa; Rachel M Knight; Tim D Braden; Crisanta Cruz-Espindola; Dawn M Boothe; Benson T Akingbemi
Journal:  Biol Reprod       Date:  2020-10-05       Impact factor: 4.285

2.  Design, Synthesis, and Evaluation of Genistein Analogues as Anti-Cancer Agents.

Authors:  Pahoua Xiong; Rubing Wang; Xiaojie Zhang; Eduardo DeLa Torre; Francisco Leon; Qiang Zhang; Shilong Zheng; Guangdi Wang; Qiao-Hong Chen
Journal:  Anticancer Agents Med Chem       Date:  2015       Impact factor: 2.505

3.  Preferential induction of G1 arrest in androgen-responsive human prostate cancer cells by androgen receptor signaling antagonists DL3 and antiandrogen bicalutamide.

Authors:  Shan Lu; Zongqin Tan; Matthew Wortman; Shan Lu; Zhongyun Dong
Journal:  Cancer Lett       Date:  2010-08-02       Impact factor: 8.679

4.  Aggressive prostate cancer is prevented in ERαKO mice and stimulated in ERβKO TRAMP mice.

Authors:  Anna Slusarz; Glenn A Jackson; J Kevin Day; Nader S Shenouda; Jennifer L Bogener; Jim D Browning; Kevin L Fritsche; Ruth S MacDonald; Cynthia L Besch-Williford; Dennis B Lubahn
Journal:  Endocrinology       Date:  2012-06-29       Impact factor: 4.736

5.  Design, synthesis, and evaluation of the antiproliferative activity of hydantoin-derived antiandrogen-genistein conjugates.

Authors:  Alex George; Idris Raji; Bekir Cinar; Omer Kucuk; Adegboyega K Oyelere
Journal:  Bioorg Med Chem       Date:  2018-02-16       Impact factor: 3.641

Review 6.  Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer.

Authors:  Georgios Kallifatidis; James J Hoy; Bal L Lokeshwar
Journal:  Semin Cancer Biol       Date:  2016-06-28       Impact factor: 15.707

Review 7.  Soy isoflavones and prostate cancer: a review of molecular mechanisms.

Authors:  Abeer M Mahmoud; Wancai Yang; Maarten C Bosland
Journal:  J Steroid Biochem Mol Biol       Date:  2013-12-25       Impact factor: 4.292

8.  BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells.

Authors:  S Fan; Q Meng; K Auborn; T Carter; E M Rosen
Journal:  Br J Cancer       Date:  2006-02-13       Impact factor: 7.640

9.  Differential effects of genistein on prostate cancer cells depend on mutational status of the androgen receptor.

Authors:  Abeer M Mahmoud; Tian Zhu; Aijaz Parray; Hifzur R Siddique; Wancai Yang; Mohammad Saleem; Maarten C Bosland
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

Review 10.  Anti-androgenic effects of flavonols in prostate cancer.

Authors:  Tristan Boam
Journal:  Ecancermedicalscience       Date:  2015-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.